Recent review conducted by a team lead by Ian M. Thompson, MD, University of Texas Health Science Center, indicated that although prostate cancer screening has increased diagnosis substantially, there is not much evidence of a survival benefit. The review co-author Otis W. Brawley, MD, of the American Cancer Society in Atlanta said that the cumulative evidence supports a recommendation against mass screening, rather than justifying its current common use in the US.